RedHill Biopharma (RDHL) Stock Chart & Stock Price History → Urgent: Protect Your Investments from a Chinese Invasion (From Behind the Markets) (Ad) Free RDHL Stock Alerts $0.53 +0.02 (+3.51%) (As of 01:45 PM ET) Add Compare Share Share ChartStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial Media RedHill Biopharma Stock Price Performance5 Day Performance+10.02%1 Month Performance-1.81%3 Month Performance-63.94%6 Month Performance-9.38%Year-To-Date Performance-63.69%1 Year Performance-89.05% Receive RDHL Stock News and Ratings via Email Sign-up to receive the latest news and ratings for RedHill Biopharma and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Behind the MarketsUrgent: Protect Your Investments from a Chinese InvasionAn alarming new reality is unfolding across America. The United States is bracing for the unthinkable - a potential Chinese invasion.Click here to get my exclusive report NOW >>> RDHL Stock Chart for Thursday, March, 28, 2024 RDHL Chart by TradingView RedHill Biopharma Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization03/27/2024$0.48$0.51+6.75%$0.53$0.48463,248 shs$15.21 million03/26/2024$0.46$0.48+3.94%$0.48$0.46293,032 shs$14.25 million03/25/2024$0.48$0.46-4.21%$0.49$0.45712,896 shs$13.71 million03/22/2024$0.51$0.48-5.12%$0.51$0.48499,730 shs$14.31 million03/21/2024$0.50$0.51+0.87%$0.51$0.50350,816 shs$15.09 million03/20/2024$0.53$0.50-4.30%$0.53$0.47852,034 shs$14.96 million Get the Latest News and Ratings for RDHL and Related StocksEnter your email address below to receive the latest news and analysts' ratings for RedHill Biopharma and its competitors with MarketBeat's FREE daily newsletter. 03/19/2024$0.54$0.53-2.32%$0.54$0.51299,392 shs$15.63 million03/18/2024$0.53$0.54+2.24%$0.54$0.52194,307 shs$16.00 million03/15/2024$0.53$0.53-0.42%$0.53$0.51428,549 shs$15.65 million03/14/2024$0.55$0.53-3.80%$0.55$0.52529,174 shs$15.71 million03/13/2024$0.54$0.55+1.03%$0.56$0.54392,462 shs$16.33 million03/12/2024$0.55$0.54-1.00%$0.56$0.53572,260 shs$16.17 million03/11/2024$0.54$0.55+2.76%$0.56$0.542.46 million shs$16.33 million03/08/2024$0.53$0.54+0.38%$0.55$0.53287,240 shs$15.89 million03/07/2024$0.56$0.53-5.33%$0.56$0.53418,528 shs$15.83 million03/06/2024$0.56$0.56+1.44%$0.57$0.55655,094 shs$16.72 million03/05/2024$0.60$0.56-7.48%$0.64$0.532.32 million shs$16.48 million03/04/2024$0.57$0.60+6.14%$0.62$0.562.22 million shs$17.82 million03/01/2024$0.62$0.57-7.93%$0.62$0.55562,749 shs$16.82 million02/29/2024$0.54$0.62+13.91%$0.65$0.532.14 million shs$18.27 million02/28/2024$0.53$0.54+2.02%$0.55$0.53193,486 shs$16.04 million02/27/2024$0.53$0.53-0.13%$0.54$0.51325,762 shs$15.72 million02/26/2024$0.54$0.53-1.40%$0.54$0.52366,494 shs$15.74 million02/23/2024$0.54$0.53-1.34%$0.55$0.51601,190 shs$15.78 million02/22/2024$0.55$0.54-2.52%$0.57$0.52401,126 shs$15.99 million02/21/2024$0.53$0.55+4.33%$0.57$0.52484,688 shs$16.40 million02/20/2024$0.55$0.53-3.85%$0.58$0.52700,385 shs$15.72 million02/19/2024$0.55$0.55$0.56$0.54265,200 shs$16.35 million02/16/2024$0.54$0.56+2.39%$0.56$0.54265,251 shs$16.53 million02/15/2024$0.56$0.54-2.39%$0.56$0.54428,720 shs$16.15 million02/14/2024$0.57$0.56-1.59%$0.57$0.53403,091 shs$16.54 million02/13/2024$0.58$0.57-2.55%$0.58$0.56297,739 shs$16.81 million02/12/2024$0.60$0.58-2.52%$0.60$0.56463,765 shs$17.25 million02/09/2024$0.53$0.60+11.97%$0.60$0.54626,253 shs$17.70 million02/08/2024$0.54$0.53-2.01%$0.55$0.52319,422 shs$15.80 million02/07/2024$0.51$0.54+5.54%$0.55$0.50431,013 shs$16.13 million02/06/2024$0.53$0.51-2.91%$0.54$0.48963,051 shs$10.12 million02/05/2024$0.57$0.53-7.04%$0.57$0.52952,098 shs$10.42 million02/02/2024$0.60$0.57-4.81%$0.60$0.55805,869 shs$11.21 million02/01/2024$0.58$0.60+3.24%$0.60$0.551.24 million shs$11.78 millionOnly a fool would buy Nvidia today… (Ad)Average people are too busy throwing their money into Nvidia, Google, and every other overvalued tech firm… while missing what could be the biggest story of the decade.In this new presentation – which Porter Stansberry details why this company could be the linchpin of01/31/2024$0.60$0.58-3.51%$0.61$0.56895,339 shs$11.41 million01/30/2024$0.64$0.60-6.57%$0.64$0.601.28 million shs$11.82 million01/29/2024$0.68$0.64-5.40%$0.68$0.611.56 million shs$12.66 million01/26/2024$0.65$0.68+4.70%$0.70$0.585.34 million shs$13.38 million01/25/2024$1.08$0.65-39.85%$0.74$0.5519.67 million shs$12.78 million01/24/2024$0.89$1.08+21.14%$1.26$1.0110.48 million shs$21.24 million01/23/2024$0.94$0.89-4.65%$0.96$0.822.69 million shs$17.54 million01/22/2024$0.94$0.94-0.25%$0.99$0.92359,490 shs$18.39 million01/19/2024$0.99$0.94-5.26%$0.98$0.92456,817 shs$18.44 million01/18/2024$1.04$0.99-4.87%$1.05$0.93657,098 shs$19.46 million01/17/2024$1.12$1.04-7.14%$1.09$1.01500,685 shs$20.46 million01/16/2024$1.06$1.12+5.66%$1.13$1.00694,779 shs$22.03 million01/15/2024$1.06$1.06$1.17$1.04840,100 shs$20.85 million01/12/2024$1.16$1.06-8.62%$1.17$1.04798,607 shs$20.85 million01/11/2024$1.23$1.16-5.31%$1.23$1.11890,937 shs$22.82 million01/10/2024$1.32$1.23-7.20%$1.33$1.21653,325 shs$24.10 million01/09/2024$1.24$1.32+6.45%$1.36$1.25732,135 shs$25.96 million01/08/2024$1.30$1.24-4.62%$1.29$1.21465,313 shs$24.39 million01/05/2024$1.43$1.30-9.09%$1.43$1.131.28 million shs$25.57 million01/04/2024$1.50$1.43-4.67%$1.53$1.41963,694 shs$28.13 million01/03/2024$1.46$1.50+2.74%$1.54$1.38879,916 shs$29.51 million01/02/2024$1.46$1.46$1.54$1.43817,752 shs$28.72 million01/01/2024$1.46$1.46$1.48$1.40554,200 shs$28.72 million12/29/2023$1.47$1.46-0.68%$1.48$1.40553,081 shs$28.72 million12/28/2023$1.38$1.47+6.52%$1.52$1.371.47 million shs$28.92 million12/27/2023$1.49$1.38-7.38%$1.59$1.371.51 million shs$27.15 million Related Companies: RenovoRx Stock Chart VBI Vaccines Stock Chart ABVC BioPharma Stock Chart Cocrystal Pharma Stock Chart NanoViricides Stock Chart TFF Pharmaceuticals Stock Chart Edesa Biotech Stock Chart Benitec Biopharma Stock Chart Purple Biotech Stock Chart NuCana Stock Chart Receive RDHL Stock News and Ratings via EmailSign-up to receive the latest news and ratings for RedHill Biopharma and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:RDHL) was last updated on 3/28/2024 by MarketBeat.com Staff From Our PartnersTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeGrab Your Free Bitcoin Today!Crypto Swap ProfitsMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceFed launches fourth dollar overhaulStansberry Research“The Stock Market’s Bull Run is Far from Over” -BarronsVertical Research AdvisorySHOCKING Footage From Tesla Gigafactory In Austin, TexasInvestorPlaceBuy this small stock before coming AI Tidal WaveChaikin AnalyticsThe 3rd Revolution in WarfareWeiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding RedHill Biopharma Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.